Lymphatic targeting with nanoparticulate system.

Area of Science:

• Drug delivery and nanomedicine
• Biomaterials science
• Pharmacology

Background:

• Colloidal carriers are extensively researched for lymphatic drug targeting.
• Biodegradable nanoparticulate systems like nanospheres, emulsions, and liposomes are key areas of development.
• Lymphatic targeting aims to enhance chemotherapy efficacy, improve diagnostic imaging, and increase oral bioavailability of macromolecular drugs.

Purpose of the Study:

• To review recent advancements in biodegradable nanoparticulate systems for lymphatic targeting.
• To evaluate the potential of nanocapsules as effective colloidal carriers for lymph node delivery.
• To present in vivo evidence supporting enhanced lymph node drug accumulation using specific nanocapsule formulations.

Main Methods:

• Review of current literature on biodegradable nanoparticulate systems for lymphatic targeting.
• Focus on nanocapsules, their fabrication via surface engineering (interfacial deposition).
• In vivo evaluation of polyisobutylcyanoacrylate nanocapsules against other carriers (emulsions, liposomes) for lymph node drug accumulation.

Main Results:

• Nanocapsules, particularly those engineered via interfacial deposition, offer promising characteristics for lymphatic targeting.
• Polyisobutylcyanoacrylate nanocapsules demonstrated significantly enhanced drug accumulation in lymph nodes.
• The in vivo study confirmed superior performance of these nanocapsules over traditional emulsions and liposomes.

Conclusions:

• Engineered nanocapsules represent a highly promising colloidal carrier system for effective lymphatic drug delivery.
• Polyisobutylcyanoacrylate nanocapsules show potential for improving anticancer chemotherapy and diagnostic applications via enhanced lymph node targeting.
• Further development in surface engineering can optimize nanocapsule properties for specific lymphatic targeting objectives.